PKR is activated in MDS patients and its subcellular localization depends on disease severity

Leukemia. 2008 Dec;22(12):2267-9. doi: 10.1038/leu.2008.122. Epub 2008 May 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Nucleus / enzymology
  • Cytoplasm / enzymology
  • Humans
  • Myelodysplastic Syndromes / epidemiology
  • Myelodysplastic Syndromes / metabolism*
  • Risk Factors
  • Severity of Illness Index*
  • eIF-2 Kinase / metabolism*

Substances

  • eIF-2 Kinase